Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Ceftazidime in Acute Myeloid Leukemia: NCT07016165 Clinical Landscape Report 2026
15 October 2026
NCT07016165 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Zolacaptagene Autoleucel in Lupus Nephritis: NCT07015983 Clinical Landscape Report 2026
15 October 2026
NCT07015983 clinical landscape for Lupus Nephritis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Darovasertib in Uveal Melanoma: NCT07015190 Clinical Landscape Report 2026
15 October 2026
NCT07015190 clinical landscape for Uveal Melanoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Carfilzomib in Refractory Multiple Myeloma: NCT07015021 Clinical Landscape Report 2026
15 October 2026
NCT07015021 clinical landscape for Refractory Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Lenalidomide in Refractory Multiple Myeloma: NCT07018050 Clinical Landscape Report 2026
15 October 2026
NCT07018050 clinical landscape for Refractory Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Dexamethasone in Acute Myeloid Leukemia: NCT07014462 Clinical Landscape Report 2026
15 October 2026
NCT07014462 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
WBC100 in Adult Acute Myeloblastic Leukemia: NCT07014449 Clinical Landscape Report 2026
15 October 2026
NCT07014449 clinical landscape for Adult Acute Myeloblastic Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
TolDC(University Hospital Antwerp) in Multiple Sclerosis, Chronic Progressive: NCT07020715 Clinical Landscape Report 2026
15 October 2026
NCT07020715 clinical landscape for Multiple Sclerosis, Chronic Progressive: endpoints, sponsor, phase, geography, readouts, asset context and development whi…
9 min read
Mecapegfilgrastim in Neutropenia: NCT07018271 Clinical Landscape Report 2026
15 October 2026
NCT07018271 clinical landscape for Neutropenia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Gemcitabine Hydrochloride in Bladder Cancer: NCT07019220 Clinical Landscape Report 2026
15 October 2026
NCT07019220 clinical landscape for Bladder Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Xylitol in Acute Myeloid Leukemia: NCT07022678 Clinical Landscape Report 2026
15 October 2026
NCT07022678 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Multi-peptide CMV-Modified Vaccinia Ankara Vaccine(City of Hope National Medical Center) in Acute Myeloid Leukemia: NCT07020533 Clinical Landscape Report 2026
15 October 2026
NCT07020533 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.